An apheresis machine separates
the blood components from the blood directed to the machine from the
patient/donor's veins through tubing. Apheresis can be used for the treatment
of various diseases such as familial hypercholesterolemia, Goodpasture's
syndrome, hyperviscosity syndrome, myasthenia gravis, the HELLP syndrome of
pregnancy, Waldenstrom's macroglobulinemia, clogging of blood vessels
(leukostasis) cause by severely elevated white blood count in leukemia, and
severely elevated platelet counts in leukemia or myeloproliferative disorders.
The global Apheresis
Equipment Market is estimated to account for US$ 2,866.4 Mn in terms of
value in 2020 and is expected to reach US$ 6,081.8 Mn by the end of 2027.
Global Apheresis Equipment
Market: Drivers
Increasing prevalence of COVID-19
is expected to propel growth of the global apheresis equipment market over the
forecast period. For instance, according to a statement by World Apheresis
Association in April 2020, apheresis therapy can be widely beneficial in the
treatment of patients with the novel coronavirus.
Global Apheresis Equipment
Market: Opportunities
Lipoprotein apheresis is
effective in the treatment of homozygous familial hypercholesterolemia.
However, the therapy is expensive and available in only a few countries.
Therefore, reduction in the cost of lipoprotein apheresis and widespread
availability of the therapy is expected to offer lucrative growth opportunities
for the market players.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/517
Global Apheresis Equipment
Market: Restraints
Lack of trained professionals,
especially in emerging economies is expected to limit growth of the market.
Hiring skilled staff for both therapeutic and donor apheresis is a major
challenge faced in both developed and emerging markets. The staff required for
apheresis comprises of a practicing doctor and a specialized nurse. Apheresis
procedures are often termed to be labor intensive since they require the staff
to be present and vigilant during the entire procedure. The skill requirement
criteria in the practice of apheresis are also different compared to conventional
therapeutic areas.
Key Takeaways:
Plasmapheresis segment was valued
at US$ 1,303.7 Mn in 2019 and is forecast to reach a value of US$ 2,735.9 Mn by
2027 at a CAGR of 9.7% between 2020 and 2027. Frequent and increasing use of
plasmapheresis is expected to support growth of the segment over the forecast
period.
Neurological disorders segment
held dominant position in the global apheresis equipment market in 2019,
accounting for 52.6% share in terms of value, followed by hematological
disorders and renal disorders, respectively. Increasing prevalence of neurological
disorders is expected to support growth of the segment over the forecast
period.
Market Trends
Increasing clinical trials for
cystinosis, a rare genetic, metabolic, lysosomal storage disease caused by
mutations in the CTNS gene on chromosome 17p13, is expected to boost adoption
of apheresis, thereby boosting growth of the market. For instance, in March
2020, AVROBIO, Inc., a clinical-stage gene therapy company, announced that a
second patient in the AVR-RD-04 Phase 1/2 clinical trial in cystinosis has been
enrolled and has completed apheresis.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/apheresis-market-517
However, several pharmaceutical
companies have suspended screening, enrollment and apheresis in clinical
studies. For instance, in March 2020, Bristol-Myers Squibb disclosed that the
company has temporarily suspended screening, enrollment and apheresis in its
cellular therapy clinical studies.
Global Apheresis Equipment Market:
Competitive Landscape
Major players operating in the
global apheresis equipment market include, Asahi Kasei Medical Co., Ltd., Terumo
BCT, Inc., Fenwal, Inc., Haemonetics Corp., Therakos, Inc., B. Braun Melsungen
AG, and HemaCare Corporation.
Global Apheresis Equipment
Market: Key Developments
April 2019: Asahi Kasei
Bioprocess America, a subsidiary of Asahi Kasei Medical Co., Ltd. started
Massachusetts Training Center, for customer training and product collaborations
in virus filtration, bioprocess and fluid management
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/517
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S. Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment